What Causes Breast Implant Illness? Understanding Toxins, Biofilm, and the Autoimmune Connection
By Leora Acoca Goldberg — founder OptimalBody New York and host of Living Life with Leora
From the interview “Healing with Lymphatic Drainage Massage” featuring Dr. Randall Feingold, MD & Dr. Perry Nickelston, DC — Living Life with Leora podcast (formerly Wednesday Wellness).
Patients researching breast implant illness (BII) often ask a version of the same question: what exactly is my body reacting to? Dr. Randall Feingold, a plastic surgeon specializing in explant procedures, offers a more nuanced answer than a single culprit.
It’s rarely just one substance
Rather than one specific toxin, Feingold describes a broader category of stressors patients are exposed to. These include:
- The implant shell itself — the solid silicone elastomer casing exists even in saline-filled implants, not just silicone-gel ones
- Silicone gel — which isn’t a pure, inert substance; it can contain trace heavy metals and other chemical compounds
- Biofilm — colonies of bacteria, and in some cases fungus or mold, that can form on and around an implant’s capsule over time
That biofilm piece is one clinicians are increasingly focused on: it represents an ongoing, low-grade source of immune activation that’s separate from — but can compound — reactions to the implant material itself.
The common symptom pattern
While not every case is confirmed autoimmune, Feingold describes a recurring cluster of symptoms across his patient population: general fatigue, brain fog, visual disturbances, hair loss, skin rashes and thickening, joint pain, and digestive intolerances. The consistency of this pattern across patients — even without a single confirmed mechanism — is part of why BII has gained increasing clinical recognition, including acknowledgment from the FDA that explant surgery improves symptoms in many women.
Why explant doesn’t always mean complete resolution
This is a nuance worth sitting with: some patients experience rapid, complete symptom resolution after explant. Others see meaningful but partial improvement — for example, patients with inflammatory arthritis conditions often reduce their medication needs without symptoms disappearing entirely. Understanding this range matters for setting realistic expectations going into surgery, and for knowing that ongoing symptom management — including support for detoxification pathways like the lymphatic system — may still be part of the picture afterward.
The bigger picture
Not every woman with implants will develop BII. The goal of understanding these mechanisms isn’t to create fear — it’s to support informed decision-making: monitoring your implants over time, understanding their limited lifespan and the eventual need to exchange or remove them, and knowing the full range of options available, including alternatives like breast lift and fat grafting for those seeking restoration without implants.
